Greece expects big investments in the production of medical cannabis which the government hopes would add up to 1.5 billion euros ($1.67 billion) annually to state revenue, Minister for Development and Investment Adonis Georgiadis said, according to greekreporter.com.
Speaking exclusively to Greek Reporter, Georgiadis maintained that medical cannabis would be produced and sold in Greece starting in 2022.
“The goal is for Greece to become the top European country in the production of medical cannabis. Greece’s environment is friendly for this particular plant and we think we will have a natural advantage,” Georgiadis told the Greek Reporter.
Medical cannabis, also called medical marijuana, is an herbal drug derived from plants of the genus Cannabis that is used as part of the treatment for a specific symptom or disease such as cancer, chronic pain, and mental disorders. The two major cannabinoids extracted from this plant that provide medical benefits include tetrahydrocannabinol (THC) and cannabidiol (CBD).
Read more at tornosnews.gr